148 related articles for article (PubMed ID: 22581331)
21. Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1.
Auyeung DJ; Kessler FK; Ritter JK
Toxicol Appl Pharmacol; 2003 Sep; 191(2):156-66. PubMed ID: 12946651
[TBL] [Abstract][Full Text] [Related]
22. Chromosome mapping and organization of the human beta-galactoside alpha 2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells.
Wang X; Vertino A; Eddy RL; Byers MG; Jani-Sait SN; Shows TB; Lau JT
J Biol Chem; 1993 Feb; 268(6):4355-61. PubMed ID: 7786324
[TBL] [Abstract][Full Text] [Related]
23. Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms.
Wuensch SA; Huang RY; Ewing J; Liang X; Lau JT
Glycobiology; 2000 Jan; 10(1):67-75. PubMed ID: 10570225
[TBL] [Abstract][Full Text] [Related]
24. Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin.
Dall'Olio F; Chiricolo M; Ceccarelli C; Minni F; Marrano D; Santini D
Int J Cancer; 2000 Oct; 88(1):58-65. PubMed ID: 10962440
[TBL] [Abstract][Full Text] [Related]
25. Genomic structure, expression, and transcriptional regulation of human Gal beta 1,3 GalNAc alpha 2,3-sialyltransferase gene.
Taniguchi A; Morishima T; Tsujita Y; Matsumoto Y; Matsumoto K
Biochem Biophys Res Commun; 2003 Jan; 300(2):570-6. PubMed ID: 12504121
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the promoter region of the human Galbeta1,3(4)GlcNAc alpha2,3-sialyltransferase III (hST3Gal III) gene.
Taniguchi A; Saito K; Kubota T; Matsumoto K
Biochim Biophys Acta; 2003 Apr; 1626(1-3):92-6. PubMed ID: 12697334
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells.
Aas-Eng DA; Asheim HC; Deggerdal A; Smeland E; Funderud S
Biochim Biophys Acta; 1995 Mar; 1261(1):166-9. PubMed ID: 7893756
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.
Feriotto G; Finotti A; Breveglieri G; Treves S; Zorzato F; Gambari R
FEBS J; 2007 Sep; 274(17):4476-90. PubMed ID: 17681019
[TBL] [Abstract][Full Text] [Related]
30. SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells.
Wang J; Liu X; Ni P; Gu Z; Fan Q
Biochem Biophys Res Commun; 2010 Mar; 393(2):291-6. PubMed ID: 20149781
[TBL] [Abstract][Full Text] [Related]
31. Beta-galactoside alpha2,6-sialyltransferase and the sialyl alpha2,6-galactosyl-linkage in tissues and cell lines.
Dall'Olio F; Malagolini N; Chiricolo M
Methods Mol Biol; 2006; 347():157-70. PubMed ID: 17072010
[TBL] [Abstract][Full Text] [Related]
32. Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation.
Svensson EC; Soreghan B; Paulson JC
J Biol Chem; 1990 Dec; 265(34):20863-8. PubMed ID: 2249992
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis B virus X protein promotes insulin-like growth factor II gene expression by inducing hypomethylation of the P3 promoter in hepatocellular carcinoma].
Tang S; Zhang S; Zhang X; Wu S; Li J; Jiang X; Zhou H; Luo Y; Cao M
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):289-94. PubMed ID: 25173229
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1, 4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene in testis and ovary cell lines.
Taniguchi A; Hioki M; Matsumoto K
Biochem Biophys Res Commun; 2003 Feb; 301(3):764-8. PubMed ID: 12565846
[TBL] [Abstract][Full Text] [Related]
35. Promoter structure and transcriptional regulation of human beta-galactoside alpha2, 3-sialyltransferase genes.
Taniguchi A
Curr Drug Targets; 2008 Apr; 9(4):310-6. PubMed ID: 18393824
[TBL] [Abstract][Full Text] [Related]
36. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
[TBL] [Abstract][Full Text] [Related]
38. Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver.
Briançon N; Bailly A; Clotman F; Jacquemin P; Lemaigre FP; Weiss MC
J Biol Chem; 2004 Aug; 279(32):33398-408. PubMed ID: 15159395
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
